摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4a-Methyl-3-oxo-3,4,4a,5-tetrahydro-2H-indeno[1,2-c]pyridazin-7-yl)-acetamide | 112127-75-0

中文名称
——
中文别名
——
英文名称
N-(4a-Methyl-3-oxo-3,4,4a,5-tetrahydro-2H-indeno[1,2-c]pyridazin-7-yl)-acetamide
英文别名
N-(4a-methyl-3-oxo-4,5-dihydro-2H-indeno[1,2-c]pyridazin-7-yl)acetamide
N-(4a-Methyl-3-oxo-3,4,4a,5-tetrahydro-2H-indeno[1,2-c]pyridazin-7-yl)-acetamide化学式
CAS
112127-75-0
化学式
C14H15N3O2
mdl
——
分子量
257.292
InChiKey
VWCKHMUAWHPDBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    315-316 °C(Solv: ethanol (64-17-5); acetic acid (64-19-7))
  • 密度:
    1.39±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    70.6
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    4'-溴苯丙酮 在 palladium on activated charcoal 盐酸sodium hydroxide硫酸氢气 、 sodium hydride 、 potassium carbonate一水合肼 作用下, 以 喹啉溶剂黄146 为溶剂, 反应 32.78h, 生成 N-(4a-Methyl-3-oxo-3,4,4a,5-tetrahydro-2H-indeno[1,2-c]pyridazin-7-yl)-acetamide
    参考文献:
    名称:
    Inotropic, vasodilator and low Km, cAMP-selective, cGMP-inhibited phosphodiesterase (PDE III) inhibitory activities of 4a-methyl-4,4a-dihydro-5H-indeno[1,2-c]pyridazin-3(2H)-ones and 4a-methyl-4,4a,5,6-tetrahydrobenzo[h]cinnolin-3(2H)-ones
    摘要:
    Novel 7-substituted-4,4a-dihydro-4a-methyl-5H-indenol[1,2-c]pyridazin-3[2H]-ones and 8-substituted-4a-methylbenzo[h]cinnolin-3[2H]-ones have been synthesized and their PDE III inhibitory, inotropic and vasodilator potencies compared with those of their normethyl analogues and their bicyclic 4,5-dihydro-6-phenylpyridazinone analogues. The structure-activity relationships of the tricyclic pyridazinones differ from those of bicyclic pyridazinones mainly in respect of the effect of introducing the methyl group into the pyridazinone ring. Whilst in the 4,5-dihydro-6-phenylpyridazin-3(2H)-ones, introduction of a 5-methyl group has been widely reported to lead to compounds of significantly greater potency, the novel tricyclic 4a-methylpyridazinones showed similar levels of inotropic, vasodilator and PDE III inhibitory potency to their normethyl analogues. Possible reasons for this difference in behaviour are discussed.
    DOI:
    10.1016/0223-5234(90)90196-a
点击查看最新优质反应信息